Eligibility NCT00079482 AML
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) See http://clinicaltrials.gov/ct2/show/study/NCT00079482

Eligibility AML NCT00079482

  1. StudyEvent: Eligibility
    1. Eligibility AML NCT00079482
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
UMLS CUI
Item Group
Einschlusskriterien
C1512693
AML
Item
boolean
C0023467
Relapse
Item
boolean
C0277556
FLT3 mutation
Item
boolean
C2348501
Age
Item
boolean
C0001779
Life expectancy
Item
boolean
C0023671
ECOG
Item
boolean
C1828127
Not pregnant nor lactating
Item
boolean
C0232973
C1518422
C0006147
Item Group
Ausschlusskriterien
C0680251
Bilirubin
Item
boolean
C0201913
ALT and AST
Item
boolean
C0001899
C0004002
Serum creatinine
Item
boolean
C0201976
Ejection fraction (EF)
Item
boolean
C0232174
Infection
Item
boolean
C0021311
Major physical or psychiatric condition
Item
boolean
CNS involvement
Item
boolean
C0449389
FLT3 inhibitor treatment
Item
boolean
C0013227
CL414898
C1333568
HIV treatment
Item
boolean
C0019693
Gastrointestinal ulceration or bleeding
Item
boolean
C0237938
C0017181
Other investigational drug
Item
boolean
C1516879